Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Open Label, Phase I ZD6474 Head and Neck Cancer Study
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR
- Status
- COMPLETED
- Phase
- PHASE3
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3
Taxotere + Cisplatin in Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1